TZ9
TZ9 is a selective Rad6 inhibitor. TZ9 inhibits Rad6B-induced histone H2A ubiquitination, downregulates intracellular β-catenin, induces G2-M arrest and apoptosis, and inhibits the proliferation and migration of metastatic human breast cancer cells[1].
Product Specifications
CAS Number
1002789-86-7
UNSPSC
12352005
Target
Apoptosis; E1/E2/E3 Enzyme
Type
Reference compound
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/TZ9.html
Concentration
10mM
Purity
99.45
Solubility
DMSO : ≥ 40 mg/mL
Smiles
O=C(OCC1=NC(N)=NC(NC2=CC=CC=C2)=N1)C3=CC=C([N+]([O-])=O)C=C3
Molecular Formula
C17H14N6O4
Molecular Weight
366.33
References & Citations
[1]Sanders MA, et al. Novel inhibitors of Rad6 ubiquitin conjugating enzyme: design, synthesis, identification, and functional characterization. Mol Cancer Ther. 2013 Apr;12 (4) :373-83.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A07880-1-Fluoro488 100 µg/Vial
Anti-MYT1L Antibody Picoband® Fluoro488 Conjugated
Sign In for Pricing
View Details 
MBS1445532-01 0.02 mg (E-Coli)
Recombinant Natrialba magadii Flagellin B4 (flaB4)
Sign In for Pricing
View Details MBS1445532-02 0.1 mg (E-Coli)
Recombinant Natrialba magadii Flagellin B4 (flaB4)
Sign In for Pricing
View Details MBS1445532-03 0.02 mg (Yeast)
Recombinant Natrialba magadii Flagellin B4 (flaB4)
Sign In for Pricing
View Details MBS1445532-04 0.1 mg (Yeast)
Recombinant Natrialba magadii Flagellin B4 (flaB4)
Sign In for Pricing
View Details MBS1445532-05 0.02 mg (Baculovirus)
Recombinant Natrialba magadii Flagellin B4 (flaB4)
Sign In for Pricing
View Details